Found: 1
Select item for more details and to access through your institution.
Efficacy and safety evaluation of Fanhdi<sup>®</sup>, a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study.
- Published in:
- Haemophilia, 2022, v. 28, n. 1, p. e23, doi. 10.1111/hae.14453
- By:
- Publication type:
- Article